News and advice
Middle Branch Partners welcomes Winfried Schaller to its Board of Advisors
Middle Branch Partners thrilled to welcome Winfried Schaller, former CEO of Lincotek Group, to our Board of Advisors.
Lenkbar LLC (US) is acquired by Intech (FR)
Middle Branch Partners initiated this deal, and advised Lenkbar LLC (US) during their agreement to be acquired by Intech, a global MedTech manufacturer and portfolio company of Montagu Private Equity of London, UK.
Acrotec Group agrees to acquire Axial Medical
Middle Branch Partners initiated this deal, and advised our client Acrotec Group, a portfolio company of The Carlyle Group, during its agreement to acquire Axial Medical, a precision MedTech manufacturer in Warminster Pennsylvania.
MBP Closed: Millstone Medical Outsourcing Acquires MycoScience and Ethide Laboratories
Middle Branch Partners sourced and advised our clients Mycoscience and Ethide Laboratories as they were acquired by Millstone Medical Outsourcing, the industry's leading partner of choice for medical manufacturers' post-manufacturing and aftermarket services.
Sales Off to Faster Than Expected Start in 2022
Mike Evers of Orthoworld estimates that orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable.
Content republished with permission from ORTHOWORLD® Inc.
UFP Technologies Acquires Advant
Our client UFP Technologies has acquired Advant Medical Molding in a non-auction, private transaction. Read more here.
Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results
Mike Evers of Orthoworld discusses how the orthopedic market finds itself in familiar territory in early 2022, with COVID infections surging to record levels. While we await fourth-quarter and full-year results from orthopedic companies, we'll summarize below our expectations and questions for the market as it enters the third year of disruption from the pandemic.
Content republished with permission from ORTHOWORLD® Inc.
Video archive of our 5/13 webinar now available
Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.
WEBINAR: MedTech M&A, Finance, and the Future
Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.
The state of European markets: a conversation with Göran Brorsson
There is no question that there is larger distance between European markets today and anytime in recent memory. This had begun before Covid-19 with protectionist trade policies and then continued up to today, as travel restrictions and limitations on visits and shut down much M/A activity, both in Europe and North America. To understand this in greater detail, Chuck Weikel discussed with Göran Brorsson, our European Partner at Middle Branch Partners, about what he is experiencing in the European market.